Skip to content
StockMarketAgent
Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

BOM/544644 stock hub

BOM/544644 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

BOM/544644is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
104.7B
Bombay Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
BOM/544644
In the news

Latest news · BOM/544644

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E45.1
P25 n/aP50 n/aP75 n/a
Trailing P/E61.1
P25 n/aP50 n/aP75 n/a
ROEn/a
P25 n/aP50 n/aP75 n/a
ROIC27.8
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All BOM/544644 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
130
Groups with data
10
Currency
INR
Showing 130 of 130 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

16
MetricValue
Country
India
Country code
IN
Employees
4,500
Enterprise value
INR 104.8B
Exchange
Bombay Stock Exchange
Financial currency
INR
First seen
2026-05-10
Industry
Pharmaceutical Preparations
Last refreshed
2026-05-10
Market cap
INR 104.7B
Price
INR 1,712
Price currency
INR
Rev Per Employee
2,986,166.67x
Sic
2834
Symbol
bom/544644
Website
https://www.coronaremedies.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

9
MetricValue
Earnings Yield
1.64%
EV Earnings
61.17x
EV/EBIT
42.1x
EV/EBITDA
35.91x
EV/Sales
7.8x
Forward P/E
45.11x
P/B ratio
15.88x
P/E ratio
61.12x
P/S ratio
7.79x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

14
MetricValue
EBIT Margin
18.51%
EBITDA Margin
21.45%
Gross margin
80.79%
Gross Profit
INR 10.9B
Gross Profit Growth
38.97%
Gross Profit Growth Q
16.36%
Net Income
INR 1.7B
Net Income Growth
89.32%
Net Income Growth Q
-8.19%
Pretax Margin
17.06%
Profit Margin
12.75%
Profit Per Employee
INR 380,764
ROIC
27.81
Roic5y
16.64

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

4
MetricValue
EPS Growth
89.35
EPS Growth Q
-8.16
Revenue Growth
32.46x
Revenue Growth Q
15.03x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

12
MetricValue
Cash
INR 539.6M
Debt
INR 627.1M
Debt EBITDA
INR 0.21
Debt Equity
INR 0.1
Equity
INR 6.6B
Interest Coverage
32.95
Net Cash
INR -87.5M
Net Cash By Market Cap
INR -0.08
Net Debt EBITDA
INR 0.03
Net Debt Equity
INR 0.01
Tangible Book Value
INR 4.9B
Tangible Book Value Per Share
INR 80.35

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
0.03%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

28
MetricValue
50-day SMA
1,606.3
All Time High
1,793.6
All Time High Change
-4.54%
All Time High Date
2026-05-06
All Time Low
1,337
All Time Low Change
28.06%
All Time Low Date
2025-12-23
ATR
61.76
Ch YTD
23.55
High
1,758
High52
1,793.6
High52 Date
2026-05-06
High52ch
-4.54%
Low
1,681.1
Low52
1,337
Low52 Date
2025-12-23
Low52ch
28.06%
Ma50ch
6.59%
RSI
60.11
RSI Monthly
0
RSI Weekly
64.1
Sharpe ratio
1.42x
Sortino ratio
2.36
Total Return
0.03%
Tr YTD
23.55
Tr1m
12.88%
Tr1w
-1.1%
Tr3m
11.43%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

4
MetricValue
Operating Income
INR 2.5B
Operating Income Growth
94.61
Operating Income Growth Q
23.41
Operating margin
18.51

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

5
MetricValue
Float
6,174,051%
Shares Insiders
69%
Shares Institutions
6%
Shares Qo Q
-0.09%
Shares Yo Y
-0.03%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

37
MetricValue
Average Volume
9,673.75x
Bv Per Share
107.8
Ch1m
12.88
Ch1w
-1.1
Ch3m
11.43
Change
-1.5%
Change From Open
-1.36
Close
1,738.3
Days Gap
-0.14
Depreciation Amortization
395,620,000
Dollar Volume
1,157,413.4
Earnings Date
2026-05-11
EBIT
INR 2.5B
EBITDA
INR 2.9B
EPS
INR 28.02
F Score
2
Fiscal Year End
March
Founded
2,004
Graham Number
260.7212
Graham Upside
-84.77
Income Tax
INR 579.5M
Is Primary Listing
0
Last Earnings Date
2026-02-02
Last Report Date
2025-12-31
Ma20
1,657.7
Ma20ch
3.29%
Next Earnings Date
2026-05-11
Open
1,735.8
Position In Range
40.38
Price Date
2026-05-08
Price EBITDA
INR 36.33
Ptbv Ratio
21.3
Relative Volume
0.07x
Revenue
13,437,750,000x
Tax By Revenue
4.31x
Tax Rate
25.27%
Volume
676
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does BOM/544644 pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns BOM/544644?

Insider, institutional, and short-interest positioning.

Institutional ownership
+6.0%
Share of float held by funds and institutions
Insider ownership
+69.0%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-0.0%
Negative means the company is buying back shares.
Technical

BOM/544644 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
60.1
Neutral momentum band
Price vs 200-day MA
n/a
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
1.42
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About BOM/544644

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bom/544644 stock rating?

bom/544644 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bom/544644 analysis?

The full report lives at /stocks/bom/544644/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bom/544644?

The latest report frames bom/544644 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bom/544644 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.